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Abstract
CP is not a diagnosis but an “umbrella term for many clinical descriptions. It refers to
a group of permanent disorders of the development of movement and posture, causing
activity limitation, that are attributed to nonprogressive disturbances that occurred in
the developing fetal or infant brain. The motor disorerders of cerebral palsy are often
accompanied by disturbances of sensation, perception, cognition. First description was
made in 19th century by William Little. CP prevalence is generally reported around 2-3
per 1000 live births in both developed and developing countries (even if  for very
different reasons). Additionally for term children CP prevalence is 1 per 1000 live births.
This rates are 6-10 times higher in preterm birth. The etiology of CP has been reported
very diverse and multifactorial as prenatal, perinatal and postnatal. The causes and risk
factors  are  congenital,  genetic,  inflammatory,  infectious,  anoxic,  traumatic  and
metabolic. Knowledge of the epidemiology and etiology of cerebral palsy is impor‐
tant. Thus, at least in some cases, early diagnosis and prevention can be achieved.
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1. Definition
Cerebral palsy (CP) is a well-recognized neurodevelopmental condition beginning in early
childhood and persisting throughout the lifetime. It was first reported by William little, who
was an orthopedic surgeon, in 1843 as cerebral paresis [1, 2]. Little focused on joint contractures
and deformities resulting from long-standing spasticity and paralysis. Additionally, he
indicated that the cause of the spasticity and paralysis was often due to damage to the brain
during infancy and, specifically, preterm birth and perinatal asphyxia [3].
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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and reproduction in any medium, provided the original work is properly cited.
The most comprehensive study until  then was published in 1862 by William Little.  The
association between a large number of patients’ clinical presentation and their birth history as
recalled by the family was described in this study. Little differentiated between the congenital
deformities observed at the time of birth, such as talipes equinovarus, and the limb deformi‐
ties that developed subsequently to preterm, difficult, or traumatic births, which he termed as
spastic rigidity. It was described as a disorder that appeared to strike children in the first year
of life, affected developmental skill progression, and did not improve over time [4].
Then, Sarah McNutt described that it continued to raise the profile of the risks of long-term
disability arising from birth trauma [5]. At the end of the nineteenth century, Sigmund Freud
suggested that CP might be rooted in the brain’s development in the womb and related
aberrant development to factors influencing the developing fetus [2, 6, 7]. In addition, in the
early 1920s, some 30 years after Freud’s comments, an American orthopedic surgeon made the
next major contribution for understanding of CP [8].
In the twentieth century, newer documented concepts of cerebral palsy have been defined.
Mac Keith and Polani [1, 8] described CP as “a persisting but not unchanging disorder of
movement and posture, occurring in the early years of life due to a nonprogressive disorder
of the brain, the result of interference during its development.” In 1964, Bax [9] reported a
description of CP suggested by an international working group that has become a classic and
is still used. It was expressed that CP is a disorder of movement and posture due to a defect
or lesion of the immature brain. Although this definition is usually all that is cited by authors,
some additional comments were added by Bax: “For practical purposes it is usual to exclude
from cerebral palsy those disorders of posture and movement which are of short duration, due
to progressive disease or due solely to mental deficiency.” Bax and his group felt that this
simple sentence can be readily translated into other languages and hoped that it may be used
universally. At that time, it was felt wiser not to define completely what they meant by
immature brain, as any such description may be restricted services to those in need. Like its
predecessors, this formulation of the CP concept placed an exclusive focus on motor aspects
and also stressed the specific consequences of early as opposed to late-acquired brain damage.
It was not formally included in the concept that cognitive, sensory, behavioral, and other
associated impairments were very prevalent in people with disordered movement and posture
due to a defect or lesion of the immature brain, a frequent significant disability. This definition
continued to emphasize the motor impairment and acknowledged its variability, previously
underscored in the MacKeith and Polani definition; it also excluded progressive disease, a
point introduced in Bax’s annotation [8]. The heterogeneity of disorders covered by the term
of CP, as well as advances in understanding of development in infants with early brain damage,
led Mutch et al. [10] to modify the definition of CP in 1992 as follows: an umbrella term covering
a group of nonprogressive, but often changing, motor impairment syndromes secondary to
lesions or anomalies of the brain arising in the early stages of development.
To underline the idea that a comprehensive approach to CP needs to be multidimensional and
that management of patients with CP almost always requires a multidisciplinary setting,
classes of disorders commonly accompanying CP have been identified and included in the
revised definition [1]. And last definition of CP, which is comprised to prior assessments and
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identifications, was made in April 2006. CP describes a group of persistent disorders of the
development of movement and posture causing activity limitations that are attributed to
nonprogressive disturbances that occurred in the developing fetal or infant brain. The motor
disorders of cerebral palsy are often accompanied by disturbances of sensation, perception,
cognition, communication, and behavior by epilepsy and secondary musculoskeletal prob‐
lems. This description was authored by the members of the executive committee functioning
in panels enriched with expertise from consultants and by comments and suggestions from
many reviewers responding to drafts provided to the international community. It is offered
for international consensus and adoption, with the intent of providing a broad spectrum of
audiences with a common conceptualization about cerebral palsy [1]. CP is defined as a group
of nonprogressive, but often changing, motor impairment syndromes secondary to lesions or
abnormalities of the brain and emerging in the early stages of development [10]. CP is a
symptom complex rather than a disease. It is a concept derived from an insult to a growing,
developing brain and therefore it is a dynamic changing clinical picture emanating from static
pathology [11]. CP may be diagnosed during the first two years of life, especially when
functional impairment is mild [12, 13].
This specification contains the concept that CP is a group of neurodevelopmental disorders
that involve numerous developing functions. As in other neurodevelopmental disorders,
various manifestations of the disordered brain may appear more significantly in different
persons or at different life periods, e.g., some aspects of the motor impairment, sensory loss,
attentional difficulty, epilepsy, musculoskeletal dysfunction, intellectual disability, and many
others maybe more prominent or more problematic at different periods of the life of a person
with CP [1].
In 2010, Blair again emphasized that CP is not a diagnosis but an “umbrella term for many
clinical descriptions.” It has covered a wide variety of clinical conditions that meet the
following four criteria:
- The presence of a disorder of movement or posture.
- Secondary to a cerebral abnormality.
- Arising early in development.
- By the time movement impairment exists, the cerebral abnormality is static.
There is no test, genetic, metabolic, immunologic, or otherwise, that demonstrates the existence
or absence of CP because there is no specified cause, cerebral pathology, or even type of motor
impairment resulting from nonprogressive cerebral pathology acquired early in life. Even as
a clinical description, these criteria fail in several aspects to achieve the precision required of
a definition [14, 15]. For example, specifying the age at which development is no longer
considered “early.” There is no agreement on this age [16].
Because it is difficult to definitively differentiate between pre- and neonatally acquired brain
damage, all those not postneonatally acquired are usually considered together. The four
criteria cannot be addressed until (a) motor development can be clearly recognized as being
normal or disordered and (b) the possibility of progressive cerebral disease can be excluded.
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Signs suggesting disordered motor control may be recognized very early in life, but accurate
prediction has only been confirmed by trained observers in the small proportion of persons
with CP born very preterm [17]. Acquisition of the cerebral abnormality may precede recog‐
nition of the motor disorder by many months or even years. However, brain-impaired infants,
particularly the most severely impaired, are at increased risk of dying before reaching an age
at which the criteria for CP can be confirmed. Early death is a competing outcome. On the other
hand, it is difficult to definitively exclude the possibility of progression or resolution at any
age. Even if cerebral pathology is static, motor abilities change in all children over time, even
if that development is grossly abnormal, making functional change an unreliable marker for
progressive cerebral pathology. Conversely, a proportion of children described as CP at an
early age catch up with their normally developing peers at a later age [18]. Therefore, the choice
of an age that must be attained before being counted as CP, as well as the age beyond which
development is no longer early, is arbitrary and depends on the interest in using the CP label.
Treating clinicians are more flexible in applying the CP label because their primary concern is
to balance the psychological effects of labeling a child having CP with the therapeutic oppor‐
tunities that the label can afford. This balance can change with time. Registers with a long
lifespan require primarily a constant definition over time, and this was the guiding principle
of the recommendation by Badawi et al. [19] that conditions historically excluded from CP (not
“diagnosed” as CP on account of having another diagnosis) continue to be excluded, even if
meeting the criteria for CP. By contrast, reliability between current observers is the guiding
principle of the more recent multicenter surveillance system in Europe, which adopted a
flowchart to decision inclusion or exclusion of cases of cerebral palsy on registration [20].
However, the reality of barriers to achieving interobserver agreement of classification is
demonstrated by the relatively poor agreement achieved with this flowchart [21]. Diagnosis
of CP is not easy. It needs time to be confirmed. Premature diagnosis leading to over-ascer‐
tainment (because of transient anomalies in preterm babies) or under-ascertainment, as stated
above, is not an unchanging condition with the clinical aspect in some cases altering as a child
develops. There is consensus that 5 years of age was the optimal age for confirmation of
diagnosis [22].
2. Epidemiology
CP prevalence is usually reported around 2–3 per 1000 live births in both developed and
developing countries for very different reasons [23, 24]. For term children, CP prevalence is 1
per 1000 live births. Additionally, for moderately preterm children (32–36 weeks’ gestation),
forecasts are 6–10 times higher and for very preterm children (less than 32 weeks’ gestation),
prevalence is 10 times higher than the moderately preterm children. CP rates for live births
show a lower prevalence for babies of birthweight less than 1000 g than for those with a
birthweight of 1000–1499 g. This paradoxical effect is caused from the high number of babies
who do not live long enough to develop CP and it disappears when forecasting prevalence for
neonatal survivors. Changes in perinatal and neonatal mortality accelerated in most countries
from the 1960s, with a huge decrease up until the late 1980s, when there was an increase in the
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absolute number of children with CP. From 1990s, there has been a plateauing of mortality
rates but a downward trend in CP rates, mainly in moderate and very low birthweight (VLBW)
children. In most studies, the CP rates in children born at term or with normal birthweight
seem rather stable over time. This finding is especially relevant since normal birthweight and
term children represent at least one-half of children with CP and, thus, it may be connected to
the persisting stagnation of CP prevalence, despite continuous improvement in perinatal care
and in mortality rates [25–27].
There were different rates of CP reported in recent five decades from different population.
Published rates from geographically defined populations show significant differences,
primarily due to variations in methods (Table 1). Variations within a reporting system over
time tend to be smaller [28].
The proportion of children described as CP increases with decreasing gestational age at birth.
The advent of mechanical ventilation to neonatal intensive care has allowed survival of
increasingly preterm births, creating a new source of high-risk neonates and perhaps a new
cause of brain damage [27].
Area Year range Number of cases Rate of per 1000
Turkey [29–31] 1990–2006
1988–2003
1990–1995
186
102
4.4
1.1
5.5
Sweden [32] 1995–1998 170 1.9
Canada [33] 1991–1995 2.7
U.S.A. [34] 2002 416 3.6
Australia [35] 1970–1998
1970–1972
1996–1998
2950 1.61
1.4
1.4
United Kingdom [36] 1984–2002
1984–1988
1999–2001
1301 2.0
2.5
1.2
Norway [37] 1996–1998 374 2.1
Danimark [38] 1971–1974
1975–1978
1979–1982
1983–1986
1987–1990
1.7
1.6
2.6
3.0
2.4
France [39] 1980–1989 261 1.78
Table 1. Published rates of CP from population-based samples.
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3. Etiological factors
The etiology of CP is very diverse and multifactorial. The causes are congenital, genetic,
inflammatory, infectious, anoxic, traumatic, and metabolic. The injury to the developing brain
may be prenatal, natal, or postnatal [40]. Due to the lack of a definitive test for CP, multiple
and different possible causes also constitute a challenge in this context. For more than 30% of
children, there are no risk factors or known etiology [41, 42] but some risk factors have
repeatedly been observed to be related to CP [43]. CP may result from one or more etiologies
and can occur at any stage from before conception to infancy, with the actual cause difficult
to determine in all cases [41, 42, 44]. Known causes according to the timing of the brain insult
can be classified, respectively, as prenatal, perinatal, and postnatal.
3.1. Prenatal causes of cerebral palsy
Among the important known causes of cerebral palsy are congenital brain malformations
including malformations of cortical development. Modern imaging techniques enable more
children with these conditions to be identified [45, 46]. Currently, problems occurring during
intrauterine development, congenital disorders, asphyxia occurring in any gestational age, and
preterm birth are thought to account for the majority of cases [47]. Neuroimaging studies
support the current thought that prenatal causes of CP, such as brain malformations, intrau‐
terine vascular malformations, and infection, are more common than birth asphyxia [48].
Although intrapartum asphyxia was originally thought to be a major reason for CP, it accounts
for only 10–20% of cases. The most frequent perinatal or neonatal etiologies in low birthweight
infants are periventricular leukomalacia (PVL), periventricular hemorrhage, and cerebral
infarction, but in infants of normal birthweight, the most common reason is hypoxicischemic
encephalopathy. Knowledge about the cortical dysplasias, of which some have a genetic basis,
is increasing rapidly [49]. Periventricular leukomalacia is a risk factor with 60–100% of patients
with PVL developing CP. In general, congenital malformations are strongly associated with
cerebral palsy [50–54]. Other known antenatal causes of cerebral palsy are vascular events
demonstrated by brain imaging (for example, middle cerebral artery occlusion), and maternal
TORCH (toxoplasmosis, rubella, cytomegalovirus, and herpes simplex) infections during the
first and second trimesters of pregnancy are the known causes of long-term neurodevelop‐
mental disabilities. In industrialized countries, the proportion of CP attributable to TORCH
infections is estimated to be almost 5% [13]. The less common causes of cerebral palsy include
metabolic disorders, maternal ingestion of toxins, and rare genetic syndromes [55].
3.2. Perinatal causes
Antepartum hemorrhage, obstructed labor, or cord prolapse can jeopardize the fetus causing
hypoxia, but essential criteria must be fulfilled before cerebral palsy can be attributed to the
acute intrapartum period [56, 57]. These criteria are metabolic acidosis in umbilical arterial
cord, fetal scalp or very early neonatal blood samples, and early onset of severe or moderate
neonatal encephalopathy in infants of >34 weeks gestation [57].
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Children with cerebral palsy, who have a history of neonatal encephalopathy, are more likely
to have had signs of intrapartum hypoxia such as meconium staining of the amniotic fluid [58].
However, there may be no evidence of perinatal asphyxia in a significant percentage of
children with neonatal encephalopathy [19]. In a systematic study, cerebral palsy was more
strongly associated with encephalopathy [59]. Severe hypoglycaemia, untreated jaundice, and
severe neonatal infection in neonatal period may be responsible for cerebral palsy [55].
3.3. Postnatal causes
Infection and injuries are responsible for most cases of postneonatally acquired cerebral palsy
in developed countries. Thanks to introduction of new vaccines, meningitis and subsequent
neurological sequelae were decreased in a large number of children. Accidental (motor vehicle
accidents and near-drowning episodes) and nonaccidental injuries may responsible for
cerebral palsy. Other reasons of postneonatally acquired cerebral palsy contain apparent life-
threatening events, cerebrovascular accidents, and following surgery for congenital malfor‐
mations. Meningitis, septicemia, malaria, and other conditions are the important causes of
cerebral palsy in developing countries [55].
The risk factors associated with CP may also be presented as maternal, paternal and sibling
factors, prenatal factors, perinatal factors, and postnatal factors.
3.4. Maternal, paternal, and sibling factors
Maternal medical conditions are associated with cerebral palsy. These include intellectual
disability, seizures [60], maternal thrombophilia [33], and thyroid disease [50, 60]; prior
reproductive loss [61] and CP in a sibling have been reported as an association with CP in the
Collaborative Perinatal Project of the National Institute of Neurological and Communicative
Disorders and Stroke [60]. Adolescent pregnants are likely to have low gestational weeks, low
birthweight, and birth traumas. Maternal age > 35 years was reported among risk factors of
CP [13]. Öztürk et al. [30] also reported that mothers of children with CP were significantly
younger, with an increase in adolescent pregnancies. Mothers of children with CP had low
gestational weeks, low birthweight, and prolonged labor.
Parental consanguinity [62, 63] and low economic status were found related to CP in two
studies [64, 65].
3.5. Prenatal risk factors
Preeclampsia is associated with an increased risk of cerebral palsy in term infants [66] but this
association does not seem to exist in preterm infants [67, 68]. It has been suggested that
preeclampsia may lead to a release of catecholamines in preterm infants, which accelerates
fetal maturation [69], but care is needed in comparing rates in infants of the same gestation,
given that preeclampsia itself can be directly responsible for preterm births. Alternatively, the
presence of preeclampsia may result in elective preterm delivery, avoiding the inflammatory
responses of spontaneous preterm labors with all their associated problems.
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Chorioamnionitis and intrauterine infection and/or inflammation are well-known risk factors
for CP. Prenatal maternal chorioamnionitis is accounting for as much as 12% of cerebral palsy
in term infants and 28% in premature infants [13, 70, 71]. According to the inflammatory
hypothesis, maternal infection can lead to elevated fetal blood and brain cytokine levels, which
might result in central nervous damage and subsequent CP [13]. Nelson et al. reported that
blood inflammatory cytokine levels in term infants that developed CP were significantly
higher than control groups [72]. A number of studies have shown that even fever itself might
be harmful. There may be toxic products of the infecting organisms or toxic effects of inflam‐
matory mediators produced by the mother, infant, or placenta. It is tempting to consider that
cytokines or other inflammatory mediators induced brain damage directly or indirectly [73,
74]. Gilles et al. [75] demonstrated that maternal trauma in pregnancy may be implicated as a
possible cause of cerebral palsy. Antepartum hemorrhage is also associated with mortality,
CP, and white matter damage in preterm infants [76].
Multiple pregnancies, also reported as a risk factor of CP, increase fourfold in twins and 18-
fold in triplets [77]. These are associated with preterm delivery, poor intrauterine growth, birth
defects, and intrapartum complications [78, 79].
Intrauterine growth restriction (IUGR) can be responsible to increase risk of neonatal morbidity
and mortality, and also seems to affect brain development [80]. In some specific variance in
the brain of IUGR infants, as restriction of the volume of gray matter, a reduced amount of the
total DNA in glia cells and neurons, and changes in cerebral hemodynamic have been reported.
This hypothesis supported by animal studies showed reduced oxygen delivery to the brain
and retarded growth of the forebrain and cerebellum [81, 82]. Several mechanisms have been
suggested for the relation between IUGR in term babies and CP. The abnormal growth may
play a direct role in causing CP or utero brain injury. Alternatively, a separate process, such
as placental insufficiency, could cause both the growth retardation and brain injury [83, 84].
Two mutations have been detected, which predispose heterozygous carriers to venous
thrombosis. One is a mutation localized to the factor V gene (factor V Leiden mutation, VL)
and second is the gene for prothrombin [85, 86]. Nelson et al. reported that placental throm‐
bosis, or neonatal stroke, may have occurred and resulted in CP [72].
Males are at higher risk of CP, perhaps because of the recently identified gender-specific
neuronal vulnerabilities [15, 87]. In the fetus, CP has been associated with intrauterine growth
restriction [88, 89] maternal factors [90, 91], other risk factors [92], and congenital anomalies
not only of the brain, head, eyes, and face, but also with noncerebral anomalies (in the apparent
absence of cerebral anomalies), particularly of the heart, limbs, and skeleton [93, 94]. The risk
of CP also increases with the number of suboptimal factors affecting a pregnancy [50, 95].
3.6. Perinatal risk factors
According to the results of World Health Report, perinatal asphyxia and high-risk pregnancy
were independent factors that correlated with CP in term and near-term newborns. In
developing countries, 4–9 million infants experience birth asphyxia annually [96]. Major events
likely to cause perinatal asphyxia include prolonged delivery, breech delivery, and emergency
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cesarean births [54, 97]. Though intrapartum factors producing asphyxia were traditionally
accepted to be the principal cause of CP, this assumption was reconsidered during the 1980s
and 1990s, and today it is suggested that 70–80% of cases of CP are due to prenatal factors and
that birth asphyxia plays a relatively minor role. Although intrapartum asphyxia is believed
to account for around 10% of CP in term and near-term infants, Swedish population-based CP
report by the Hagberg group detected birth asphyxia to be the likely cause of CP in 28% of
term children with CP [98]. However, “birth asphyxia” is a poorly defined term related to a
sequence initiated by hypoxia and its clinical signs are nonspecific [43]. Using indirect signs
of birth asphyxia, recent studies suggest that birth asphyxia might not be such an important
cause of CP as was previously assumed, but that it might sometimes constitute one element
of a multifactorial cause; neonatal signs associated with birth asphyxia might be early mani‐
festations of CP from a variety of causes, of which birth asphyxia is only one; and the majority
of pathways to CP commence antenatally [13, 43, 99]. Any factor causing a very preterm birth
that lies on a potential causal path to CP must be remembered. Many etiologic studies control
or stratify the risk of CP that also increases with the number of suboptimal factors affecting a
pregnancy [100].
The lower birthweights and shorter gestations associated with multiple birth contribute
significantly to their higher risk of CP, but cannot be the only relevant factors because gestation-
specific rates are higher for multiples than for singletons born at term or extremely preterm
[101, 102]. The most important risk factor seems to be prematurity, and low birthweight with
risk of CP increasing with decreasing gestational age and birthweight. About 28% of CP cases
are born very preterm, compared to 1% of all births. As an effect of the success of neonatal
intensive care during the last three decades, ensuring an increasing survival of children born
extremely preterm, the prevalence of CP among preterm children has risen [103]. These groups
of children may contribute significantly to the overall number of children with CP since they
are at greater risk of developing CP. Although it can be expected that where mortality rates
are high and CP rates are low, It may be that thanks to good clinical practice and developing
technology mortality and CP prevalence rate will be reduced. Neonatal intensive care
practices, including withdrawal of life support, may have an impact on local CP rates over
time; this influence is difficult to assess [13, 104].
Abruptio placentae have also been suggested to be associated with a higher risk of CP,
especially moderately preterm (32–36 weeks) groups [105]. Perinatal infections (bacterial, viral,
and protozoal) may also cause the development of CP [106].
Other relations with cerebral palsy include prolonged rupture of the membranes in infants of
all gestations [52] and in preterm babies [67]; the presence of meconium-stained fluid [107]
and tight nuchal cord was also reported as associated with CP [108].
3.7. Postnatal risk factors of CP
Postneonatally acquired CP is said to result from a recognized brain damaging event that is
unrelated to factors in the antenatal or perinatal period, but there is a growing realization that
the pathway to postneonatally acquired CP often begins before the postneonatal period [19].
The inclusion criteria for a postneonatal time range of the insult vary between reports. Some
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researchers have included cases acquired from neonatal causes that might have had their origin
during pregnancy, labor, or delivery [109]. Although a strict definition of beyond 28 days is
used by others [16], the upper age limit also varied from 2 to 10 years between researchers
[110]. Population-based estimates of the frequency of postneonatally acquired CP, as a
proportion of all CP, are reported in the literature to change between 1.4 and 24%, with higher
rates in undeveloped and developing countries, and lower socio-economic groups [16]. The
Surveillance of Cerebral Palsy in Europe, in a cohort of children from eight countries born
between 1976 and 1990, reported that the rate of children whose CP was of postneonatal origin
was 7.8% [39]. Pharoah et al. suggested that postnatal causes are generally resulted in spastic
CP [111]. Most surveillance systems distinguish cases in which motor impairment is obviously
acquired postneonatally, usually following cerebral infection or head trauma [16]. Other
infection complications, cerebrovascular accidents, trauma, hypoxia, gastroenteritis, and other
causes of acute encephalopathy, neoplasmas, and exposure toxins were other reasons that are
reported [112]. Infection, however, remains an important cause of acquired CP despite a fall
in the overall numbers more than 30 years of the study. With the introduction of new vaccines,
the proportion of cases due to infection will be further decrease, providing there is adequate
education and regular control [16].
CP is a nonprogressive but permanent disorder. The disease has been better understood by
the researchers in due course of time, and then described as “CP is not a diagnosis but an
umbrella term.” Though there are different rates according to the region, percentage of CP is
not low in especially developing and undeveloped countries. Etiological factors of CP are very
diverse and may be classified according to time period (prenatal, perinatal, postneonatal) and
parenteral factors. It may be that, thanks to good clinical practice and developing technology,
the prevalence of CP rate will be reduced and additionally most known risk factors will be
avoided.
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